Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

DHT stops hair regrowth in mice, similar to human hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Overweight women with PCOS are more likely to have excess male hormones.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

AR gene not major factor in female hair loss; different from male hair loss.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Overweight smokers have worse hair loss.

Acne is an important sign of androgen excess disorders in women.

Hair thickness matters more than density for baldness in Japanese men over 25.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.